Herbal & Supplement Interactions
High-yield Verified · Oct 2026Herbal and dietary supplements are products that, unlike drugs, are not FDA-approved before sale and can interact with prescription medicines — St. John’s wort weakens many drugs, and several herbs raise bleeding risk.
The interactions that make over-the-counter herbs dangerous — how St. John’s wort weakens other drugs, and which supplements make you bleed.
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 “Natural” does not mean “safe”
Herbal products and dietary supplements are pharmacologically active drugs — they just aren’t regulated like them. In the US they are sold as supplements, not medicines, so they are not FDA-reviewed for safety or efficacy before sale, potency can vary between products (and may not match the label), and contamination or adulteration occurs. Some patients assume “natural” means harmless, and many don’t mention them to clinicians.
That combination — active compounds, inconsistent dosing, and under-reporting — is exactly what makes interactions dangerous. A key nursing action for this whole topic is simple: specifically ask every patient what herbs, vitamins, and supplements they take, because they usually won’t volunteer it.
02 St. John’s wort — the enzyme inducer that weakens other drugs
St. John’s wort (taken for depression) is a classic, high-risk herbal interaction. It is a potent inducer of CYP3A4 and P-glycoprotein — it revs up the liver’s drug-metabolizing machinery, so it speeds the breakdown of many other drugs and LOWERS their blood levels. The result is therapeutic failure of the affected drug.
The consequences are serious and specific: oral contraceptives fail (breakthrough bleeding and unplanned pregnancy), warfarin loses effect (falling INR → clot risk), and transplant immunosuppressants (cyclosporine, tacrolimus) drop into the rejection range. Digoxin, HIV protease inhibitors, and many others are similarly reduced. Separately, because St. John’s wort itself raises serotonin, combining it with SSRIs, SNRIs, MAOIs, or triptans can cause serotonin syndrome. Note the two-sided danger: a patient who starts or stops St. John’s wort while on these drugs shifts their levels either way.
03 The bleeding cluster — and other notable supplements
A group of common supplements increase bleeding risk, a real danger when a patient also takes an anticoagulant or antiplatelet or is heading to surgery. Remember the “G” herbs — ginkgo, garlic, ginger, ginseng — plus vitamin E and fish oil (omega-3s): all can inhibit platelets or add to anticoagulation, although in one trial American ginseng lowered the INR of people taking warfarin. Many clinicians advise stopping these ~1–2 weeks before surgery.
A few others are worth knowing: ephedra (ma huang) — a stimulant linked to hypertension, arrhythmia, MI, and stroke (banned from US supplements); kava — associated with hepatotoxicity; valerian and kava — additive CNS sedation with alcohol/benzodiazepines/opioids; and potassium or licorice effects on electrolytes. The through-line: reconcile supplements just like prescription drugs.
Drug names
Indications
- Not prescribed — these are patient-initiated OTC products; this section is about screening and interactions
- Common patient reasons: St. John’s wort (depression), ginkgo (memory), garlic (cholesterol/BP), echinacea (colds), valerian (sleep)
Mechanism of action
Interactions arise pharmacokinetically and pharmacodynamically. St. John’s wort induces CYP3A4 and P-glycoprotein, accelerating metabolism/efflux of many drugs and lowering their levels. Antiplatelet/anticoagulant herbs (ginkgo, garlic, ginger, ginseng) and vitamin E/fish oil add to bleeding tendency. Others act via sympathomimetic (ephedra), sedative (valerian, kava), or hepatotoxic (kava) effects.
Therapeutic effects — what you'll see working
The nursing “therapeutic goal” here is safety: identify supplement use, catch dangerous interactions before they cause harm, and counsel patients — not to endorse or dose the products.
- Interaction identified & prevented
- A complete supplement history lets the team catch enzyme-induction and bleeding interactions before a drug fails or a bleed occurs.
- Informed patient decisions
- Honest, non-judgmental counseling helps patients weigh unregulated supplements against their prescription therapy.
Adverse effects
The “adverse effects” of this topic are the interactions themselves — a prescription drug failing, or unexpected bleeding.
Interactions
Contraindications
Most of these are situations where a supplement must be identified and usually stopped; St. John’s wort with certain HIV drugs, transplant drugs, warfarin, Paxlovid, or irinotecan is listed as contraindicated.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
How do Herbal & Supplement Interactions work?
What are the serious side effects of Herbal & Supplement Interactions?
See also
Prevent clot formation. High-alert medications — bleeding precautions essential.
First-line antidepressants that raise synaptic serotonin. Delayed onset; watch for serotonin syndrome and early suicidality.
Stop platelets from clumping — the arterial-clot drugs. Distinct from anticoagulants; do not stop after a stent.
Sources
- St. John's Wort — CYP3A4/P-gp induction, contraceptive/warfarin/cyclosporine interactions, serotonin syndrome — StatPearls (NCBI)
- Herbal Supplements — common supplements, regulation, bleeding and CYP interactions — StatPearls (NCBI)
- Ginkgo Biloba — bleeding risk with anticoagulants, garlic, ginger, ginseng — StatPearls (NCBI)
- Ephedrine — supplement use abandoned after links to ventricular arrhythmias — StatPearls (NCBI)
- Licorice — mineralocorticoid effects: hypertension, hypokalemia, arrhythmias (LiverTox) — LiverTox (NIDDK)
- St. John’s Wort — weakens birth control, cyclosporine, digoxin, HIV drugs, warfarin, anticonvulsants, some cancer drugs; serotonin effects; sun sensitivity (NCCIH) — NIH NCCIH
- Ginkgo — bleeding risk with anticoagulants (NCCIH) — NIH NCCIH
- Garlic — bleeding risk, surgery (NCCIH) — NIH NCCIH
- Ephedra — FDA ban (2004), cardiovascular harms (NCCIH) — NIH NCCIH
- Using Dietary Supplements Wisely — FDA regulation, undeclared ingredients, surgery (NCCIH) — NIH NCCIH
- Asian Ginseng — may interfere with blood clotting (NCCIH) — NIH NCCIH
- Kava — liver injury; avoid with sedatives (NCCIH) — NIH NCCIH
- Valerian — avoid with alcohol or sedatives (NCCIH) — NIH NCCIH
- Echinacea — uses and safety (NCCIH) — NIH NCCIH
- Licorice Root — irregular heartbeat with glycyrrhizin (NCCIH) — NIH NCCIH
- Vitamin E — bleeding risk with anticoagulants/antiplatelets (NIH ODS) — NIH Office of Dietary Supplements
- Omega-3 Fatty Acids — fish oil antiplatelet effects (NIH ODS) — NIH Office of Dietary Supplements
- St John’s wort drug interactions — PXR/CYP3A4/P-gp induction (Br J Pharmacol, CC BY) — PubMed Central
- Perioperative herbal medicine use — stop herbs two weeks before surgery (BMC, CC BY) — PubMed Central
- Perioperative medication management — supplement discontinuation 7 days to 2 weeks (JTCVS Open, CC BY-NC-ND) — PubMed Central
- Herb–cyclosporine interactions — St John’s wort and transplant rejection (J Toxicol, CC BY) — PubMed Central
- St John’s wort enzyme induction resolves about one week after stopping (Molecules, CC BY) — PubMed Central
- Over-the-counter supplement use — sedative herbs (valerian, kava) with opioids (Rheumatol Adv Pract, CC BY-NC) — PubMed Central
- Potassium — supplements, salt substitutes, and hyperkalemia with ACE inhibitors/ARBs (NIH ODS) — NIH Office of Dietary Supplements
- St John’s wort safety issues — decreased INR with warfarin (BMC, CC BY) — PubMed Central
- Kava review — caution in liver disease; additive sedation with opioids and alcohol (Nutrients, CC BY) — PubMed Central
- KALETRA (lopinavir/ritonavir) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- PREZISTA (darunavir) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- GENVOYA (cobicistat-boosted elvitegravir regimen) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- EDURANT (rilpivirine) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- PIFELTRO (doravirine) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- ZOLOFT (sertraline) — serotonin syndrome risk with triptans and St. John’s wort (FDA label) — DailyMed (NLM)
- JANTOVEN (warfarin) — St. John’s wort and ginseng may decrease its effect (FDA label) — DailyMed (NLM)
- RUKOBIA (fostemsavir) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- SUNLENCA (lenacapavir) — St. John’s wort contraindicated (FDA label) — DailyMed (NLM)
- PAXLOVID (nirmatrelvir/ritonavir) — contraindicated with St. John’s wort (FDA label) — DailyMed (NLM)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.